According to the complaint, McKesson raised the prices of over 400 prescription drugs by 25 percent, knowing those stated prices would be relied upon by the state to determine reimbursements for those drugs, according to a Richmond Times-Dispatch report.
Virginia did not participate in the $151 million settlement reached last year between McKesson and 29 states’ Medicaid programs over the same allegations.
“Our office refused to participate in a national settlement led by the Department of Justice because we needed to send a message that Virginia will fight to protect its Medicaid program from fraud and because the original settlement didn’t cover the total loss to our Medicaid program,” said Virginia Attorney General Ken Cuccinelli said in a statement. “This $37 million recovery shows that we will not tolerate Medicaid fraud in Virginia.”
More Articles on Healthcare Lawsuits:
Court Dismisses Class Action Suit Over UCLA Data Breach
St. Luke’s CEO: We’re Trying to Change Healthcare, Not Gain Market Share
CaroMont Health Sues Cogent Healthcare Over Alleged Unfair Practices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
